title: NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
abstract: These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.
authors.affiliation: Robert H. Lurie Comprehensive Cancer Center of Northwestern University
authors.forename: William J
authors.initials: WJ
authors.lastname: Gradishar
authors.affiliation: Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
authors.forename: Benjamin O
authors.initials: BO
authors.lastname: Anderson
authors.affiliation: UCSF Helen Diller Family Comprehensive Cancer Center
authors.forename: Ron
authors.initials: R
authors.lastname: Balassanian
authors.affiliation: UC San Diego Moores Cancer Center
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Blair
authors.affiliation: Dana-Farber/Brigham and Women’s Cancer Center
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Burstein
authors.affiliation: Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
authors.forename: Amy
authors.initials: A
authors.lastname: Cyr
authors.affiliation: University of Colorado Cancer Center
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Elias
authors.affiliation: The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
authors.forename: William B
authors.initials: WB
authors.lastname: Farrar
authors.affiliation: University of Alabama at Birmingham Comprehensive Cancer Center
authors.forename: Andres
authors.initials: A
authors.lastname: Forero
authors.affiliation: The University of Texas MD Anderson Cancer Center
authors.forename: Sharon Hermes
authors.initials: SH
authors.lastname: Giordano
authors.affiliation: Mayo Clinic Cancer Center
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Goetz
authors.affiliation: Fox Chase Cancer Center
authors.forename: Lori J
authors.initials: LJ
authors.lastname: Goldstein
authors.affiliation: Massachusetts General Hospital Cancer Center
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Isakoff
authors.affiliation: Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
authors.forename: Janice
authors.initials: J
authors.lastname: Lyons
authors.affiliation: Duke Cancer Institute
authors.forename: P Kelly
authors.initials: PK
authors.lastname: Marcom
authors.affiliation: Vanderbilt-Ingram Cancer Center
authors.forename: Ingrid A
authors.initials: IA
authors.lastname: Mayer
authors.affiliation: Memorial Sloan Kettering Cancer Center
authors.forename: Beryl
authors.initials: B
authors.lastname: McCormick
authors.affiliation: Yale Cancer Center/Smilow Cancer Hospital
authors.forename: Meena S
authors.initials: MS
authors.lastname: Moran
authors.affiliation: University of Wisconsin Carbone Cancer Center
authors.forename: Ruth M
authors.initials: RM
authors.lastname: O'Regan
authors.affiliation: Fox Chase Cancer Center
authors.forename: Sameer A
authors.initials: SA
authors.lastname: Patel
authors.affiliation: University of Michigan Comprehensive Cancer Center
authors.forename: Lori J
authors.initials: LJ
authors.lastname: Pierce
authors.affiliation: Fred & Pamela Buffett Cancer Center
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Reed
authors.affiliation: Roswell Park Cancer Institute
authors.forename: Kilian E
authors.initials: KE
authors.lastname: Salerno
authors.affiliation: St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
authors.forename: Lee S
authors.initials: LS
authors.lastname: Schwartzberg
authors.affiliation: UC San Diego Moores Cancer Center
authors.forename: Amy
authors.initials: A
authors.lastname: Sitapati
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
authors.forename: Karen Lisa
authors.initials: KL
authors.lastname: Smith
authors.affiliation: Research Advocacy Network
authors.forename: Mary Lou
authors.initials: ML
authors.lastname: Smith
authors.affiliation: Moffitt Cancer Center
authors.forename: Hatem
authors.initials: H
authors.lastname: Soliman
authors.affiliation: City of Hope Comprehensive Cancer Center
authors.forename: George
authors.initials: G
authors.lastname: Somlo
authors.affiliation: Stanford Cancer Institute
authors.forename: Melinda
authors.initials: M
authors.lastname: Telli
authors.affiliation: Huntsman Cancer Institute at the University of Utah
authors.forename: John H
authors.initials: JH
authors.lastname: Ward
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Dorothy A
authors.initials: DA
authors.lastname: Shead
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Rashmi
authors.initials: R
authors.lastname: Kumar
mesh_terms: D001365:Axilla; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D019468:Disease Management; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D021701:Sentinel Lymph Node Biopsy